Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval – a useful approach to pandemic vaccine development even in less well developed countries?
Open Access
- 1 November 2008
- journal article
- clinical trial
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 2 (6) , 221-228
- https://doi.org/10.1111/j.1750-2659.2008.00055.x
Abstract
Objective Seasonal vaccination has been consistently shown to significantly reduce morbidity and mortality because of influenza epidemics, even in healthy, working adults. Here we report the results of the yearly licensing studies of the past 11 influenza seasons (1997–2007) with a trivalent, inactivated whole virus vaccine with an aluminum phosphate adjuvant system.Keywords
This publication has 18 references indexed in Scilit:
- Safety and Immunogenicity of a Prepandemic Influenza A (H5N1) Vaccine in ChildrenThe Pediatric Infectious Disease Journal, 2008
- Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trialThe Lancet, 2007
- Seasonal and Pandemic Influenza Preparedness: Science and CountermeasuresThe Journal of Infectious Diseases, 2006
- Vaccines for Seasonal and Pandemic InfluenzaThe Journal of Infectious Diseases, 2006
- Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trialThe Lancet, 2006
- Confronting the avian influenza threat: vaccine development for a potential pandemicThe Lancet Infectious Diseases, 2004
- Developing vaccines against pandemic influenzaPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- The Effectiveness of Vaccination against Influenza in Healthy, Working AdultsNew England Journal of Medicine, 1995
- Viral Respiratory Disease at Lowry Air Force Base in Denver, 1952-1982The Journal of Infectious Diseases, 1983
- Purified precipitated virus obtained by a new simple method.1952